BIOMAT Database Logo BIOMAT Database Logo

Determination of insulin requirements in brittle diabetic patients by the artificial pancreas. 1978

A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010179 Pancreas A nodular organ in the ABDOMEN that contains a mixture of ENDOCRINE GLANDS and EXOCRINE GLANDS. The small endocrine portion consists of the ISLETS OF LANGERHANS secreting a number of hormones into the blood stream. The large exocrine portion (EXOCRINE PANCREAS) is a compound acinar gland that secretes several digestive enzymes into the pancreatic ductal system that empties into the DUODENUM.
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
Effect of guar gum on 24-hour insulin requirements of insulin-dependent diabetic subjects as assessed by an artificial pancreas.
January 1980, Diabetes care,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
[Dawn phenomenon. Studies using artificial pancreas in insulin dependent diabetic patients].
June 1988, Medicina clinica,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
[Analysis of the daily insulin requirements as determined by a biostator (artificial pancreas) in patients with insulin-dependent diabetes mellitus].
January 1983, Srpski arhiv za celokupno lekarstvo,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: assessment by the artificial pancreas.
July 1982, Diabetologia,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
[Evaluation of the insulin requirements with an artificial pancreas in gestational diabetes].
June 1989, Medicina clinica,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
[The role of dietary carbohydrates and proteins in the determination of postprandial insulin requirements, evaluated by artificial pancreas, in type I diabetics].
April 1983, Bollettino della Societa italiana di biologia sperimentale,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients.
January 1983, Diabetes care,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
Biologic activities of biosynthetic human insulin in healthy volunteers and insulin-dependent diabetic patients monitored by the artificial endocrine pancreas.
January 1981, Diabetes care,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
[Therapeutic hyperinsulinism induced by the use of continuous insulin infusion pumps and the artificial pancreas in diabetic patients].
September 1983, Medicina clinica,
A E Lambert, and M Buysschaert, and E Marchand, and M Pierard, and S Wojcik, and L Lambotte
Insulin Requirements of Diabetic Out-Patients.
May 1935, Edinburgh medical journal,
Copied contents to your clipboard!